Oda A - Search Results

1

Novel androgen receptor full antagonists: Design, synthesis, and a docking study of glycerol and aminoglycerol derivatives that contain p-carborane cages.

Kaise A, Ohta K, Fujii S, Oda A, Goto T, Endo Y. Kaise A, et al. Among authors: oda a. Bioorg Med Chem. 2018 Jul 30;26(13):3805-3811. doi: 10.1016/j.bmc.2018.06.007. Epub 2018 Jun 7. Bioorg Med Chem. 2018. PMID: 29903411

2

Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile.

Ohta K, Goto T, Fujii S, Kawahata M, Oda A, Ohta S, Yamaguchi K, Hirono S, Endo Y. Ohta K, et al. Among authors: oda a. Bioorg Med Chem. 2011 Jun 1;19(11):3540-8. doi: 10.1016/j.bmc.2011.04.017. Epub 2011 Apr 20. Bioorg Med Chem. 2011. PMID: 21536446

3

Functional characterization of wild-type and 49 CYP2D6 allelic variants for N-desmethyltamoxifen 4-hydroxylation activity.

Muroi Y, Saito T, Takahashi M, Sakuyama K, Niinuma Y, Ito M, Tsukada C, Ohta K, Endo Y, Oda A, Hirasawa N, Hiratsuka M. Muroi Y, et al. Among authors: oda a. Drug Metab Pharmacokinet. 2014;29(5):360-6. doi: 10.2133/dmpk.dmpk-14-rg-014. Epub 2014 Mar 18. Drug Metab Pharmacokinet. 2014. PMID: 24647041 Free article.

4

Aliphatic substitution of o-carboranyl phenols enhances estrogen receptor beta selectivity.

Ohta K, Ogawa T, Kaise A, Oda A, Endo Y. Ohta K, et al. Among authors: oda a. Chem Pharm Bull (Tokyo). 2014;62(4):386-91. doi: 10.1248/cpb.c13-00796. Chem Pharm Bull (Tokyo). 2014. PMID: 24695349 Free article.

5

Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring.

Nakagawa-Goto K, Oda A, Hamel E, Ohkoshi E, Lee KH, Goto M. Nakagawa-Goto K, et al. Among authors: oda a. J Med Chem. 2015 Mar 12;58(5):2378-89. doi: 10.1021/jm501859j. Epub 2015 Feb 26. J Med Chem. 2015. PMID: 25695315 Free PMC article.

6

Design and synthesis of carborane-containing estrogen receptor-beta (ERβ)-selective ligands.

Ohta K, Ogawa T, Oda A, Kaise A, Endo Y. Ohta K, et al. Among authors: oda a. Bioorg Med Chem Lett. 2015 Oct 1;25(19):4174-8. doi: 10.1016/j.bmcl.2015.08.007. Epub 2015 Aug 7. Bioorg Med Chem Lett. 2015. PMID: 26298498

7

Estrogenic activity of bis(4-hydroxyphenyl)methanes with cyclic hydrophobic structure.

Kojima T, Ogawa T, Kitao S, Sato M, Oda A, Ohta K, Endo Y. Kojima T, et al. Among authors: oda a. Bioorg Med Chem. 2015 Nov 1;23(21):6900-11. doi: 10.1016/j.bmc.2015.09.046. Epub 2015 Oct 1. Bioorg Med Chem. 2015. PMID: 26462053

8

Triethylated chromones with substituted naphthalenes as tubulin inhibitors.

Nakagawa-Goto K, Taniguchi Y, Watanabe Y, Oda A, Ohkoshi E, Hamel E, Lee KH, Goto M. Nakagawa-Goto K, et al. Among authors: oda a. Bioorg Med Chem. 2016 Nov 15;24(22):6048-6057. doi: 10.1016/j.bmc.2016.09.062. Epub 2016 Sep 25. Bioorg Med Chem. 2016. PMID: 27707623 Free PMC article.

9

ER subtype selectivity of m-carborane-containing phenols: C-alkyl groups on the m-carborane cage enhance ERα selectivity.

Ohta K, Ogawa T, Kato K, Oda A, Endo Y. Ohta K, et al. Among authors: oda a. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2290-2293. doi: 10.1016/j.bmcl.2019.06.025. Epub 2019 Jun 19. Bioorg Med Chem Lett. 2019. PMID: 31248773

10

Development of Force Field Parameters for p-Carborane to Investigate the Structural Influence of Carborane Derivatives on Drug Targets by Complex Formation.

Kato K, Nakayoshi T, Inoue H, Fukuyoshi S, Ohta K, Endo Y, Kurimoto E, Oda A. Kato K, et al. Among authors: oda a. Biol Pharm Bull. 2020;43(12):1931-1939. doi: 10.1248/bpb.b20-00656. Biol Pharm Bull. 2020. PMID: 33268711 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

561 results

Search Page

Filters